Related Experiment Video
Updated: Jan 8, 2026
11:07
Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
Published on: April 14, 2022
2.7K
Myasthenia Gravis - An Updated Review
1Wills Eye Hospital.
International Ophthalmology Clinics
|December 22, 2025
Summary
Myasthenia gravis (MG) is an autoimmune neuromuscular junction disorder causing muscle weakness due to antibodies against acetylcholine receptors. Management involves medications, immunotherapies, and sometimes surgery, with new treatments emerging.
Area of Science:
- Neurology
- Immunology
- Muscle Physiology
Background:
- Myasthenia gravis (MG) is an autoimmune disorder affecting the neuromuscular junction (NMJ).
- It is characterized by antibodies targeting acetylcholine receptors (AChR), leading to muscle weakness.
- Symptoms range from ocular muscle involvement to generalized weakness, including potentially life-threatening myasthenic crisis.
Purpose of the Study:
- To provide a comprehensive overview of myasthenia gravis.
- To discuss the diagnostic criteria and management strategies for MG.
- To highlight recent advancements in therapeutic options for MG.
Main Methods:
- Review of existing literature on myasthenia gravis.
- Analysis of diagnostic approaches including clinical examination, serology, and electrophysiology.
- Summary of current and emerging treatment modalities.
Main Results:
- MG diagnosis is based on characteristic symptoms and confirmed by specific tests.
- Treatment is multimodal, often requiring a combination of therapies.
- Novel therapeutics are expanding treatment possibilities.
Conclusions:
- Myasthenia gravis is a complex autoimmune NMJ disorder requiring tailored management.
- Early diagnosis and appropriate treatment are crucial for patient outcomes.
- Ongoing research is leading to more effective treatment options for MG patients.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
01:15Myasthenia Gravis: Diagnostic Tests
1.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
01:28Disorders of the Skeletal Muscle
1.6K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.6K
01:26Chemical Synapses
11.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
11.1K
01:26Chemical Synapses
4.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
4.2K
01:22Myocarditis IV: Nursing Management
191
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
191